Human cytochromes P450: problems and prospects.

[1]  R. Hayes,et al.  Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. , 1992, Pharmacogenetics.

[2]  P. Beaune,et al.  Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens. , 1992, Molecular pharmacology.

[3]  F. Gonzalez,et al.  Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1. , 1992, Pharmacogenetics.

[4]  J. Idle,et al.  Comparison of a novel thin-layer chromatographic-fluorescence detection method with a spectrofluorometric method for the determination of 7-hydroxycoumarin in human urine. , 1992, Journal of chromatography.

[5]  F. Gonzalez,et al.  Metabolic activation of the pneumotoxin, 3-methylindole, by vaccinia-expressed cytochrome P450s. , 1991, Biochemical and biophysical research communications.

[6]  K. Nakachi,et al.  Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. , 1991, Cancer research.

[7]  A. Brøgger,et al.  Human CYP1A1 (cytochrome P(1)450) gene: lack of association between the Msp I restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population. , 1991, Pharmacogenetics.

[8]  D W Nebert,et al.  Proposed role of drug-metabolizing enzymes: regulation of steady state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine functions. , 1991, Molecular endocrinology.

[9]  M. Kikuchi,et al.  Defective provirus form of human T-cell leukemia virus type I in adult T-cell leukemia/lymphoma: clinicopathological features. , 1991, Cancer research.

[10]  K. Nakachi,et al.  Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. , 1991, Journal of biochemistry.

[11]  U. Meyer,et al.  Polymerase chain reaction-directed identification, cloning, and quantification of human CYP2C18 mRNA. , 1991, Molecular pharmacology.

[12]  T. Shimada,et al.  Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. , 1991, Chemical research in toxicology.

[13]  P. Srivastava,et al.  Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes. , 1991, Molecular Pharmacology.

[14]  M. J. Coon,et al.  The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature. , 1991, DNA and cell biology.

[15]  O. Mcbride,et al.  Localization of CYP2F1 by multipoint linkage analysis and pulsed-field gel electrophoresis. , 1991, Genomics.

[16]  D. Nebert,et al.  Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP. , 1991, American journal of human genetics.

[17]  F. Gonzalez,et al.  DNA-expressed human cytochrome P450s: a new age of molecular toxicology and human risk assessment. , 1991, Mutation research.

[18]  F. Gonzalez,et al.  Molecular genetics of the debrisoquin‐sparteine polymorphism , 1991, Clinical pharmacology and therapeutics.

[19]  T. Kamataki,et al.  Molecular toxicology on cytochrome P-450 in human fetal livers. , 1991, The Journal of toxicological sciences.

[20]  B. Tang,et al.  Caffeine as a metabolic probe: Exploration of the enzyme‐inducing effect of cigarette smoking , 1991, Clinical pharmacology and therapeutics.

[21]  D. Schoeller,et al.  The caffeine breath test and caffeine urinary metabolite ratios in the Michigan cohort exposed to polybrominated biphenyls: a preliminary study. , 1990, Environmental health perspectives.

[22]  P. Saenger,et al.  Cytochrome P450IIE1 is elevated in lymphocytes from poorly controlled insulin-dependent diabetics. , 1990, The Journal of clinical endocrinology and metabolism.

[23]  M. Boyd,et al.  Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. , 1990, Journal of the National Cancer Institute.

[24]  C. Kozak,et al.  The human CYP2F gene subfamily: identification of a cDNA encoding a new cytochrome P450, cDNA-directed expression, and chromosome mapping. , 1990, Biochemistry.

[25]  J. S. Miles,et al.  Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity. , 1990, The Biochemical journal.

[26]  F. Gonzalez,et al.  The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. , 1990, Biochemistry.

[27]  O. Mcbride,et al.  Identification of a new P450 expressed in human lung: complete cDNA sequence, cDNA-directed expression, and chromosome mapping. , 1989, Biochemistry.

[28]  D. Nelson,et al.  Evolution of the cytochrome P450 genes. , 1989, Xenobiotica; the fate of foreign compounds in biological systems.

[29]  T. Aoyama,et al.  cDNA cloning and sequence and cDNA-directed expression of human P450 IIB1: identification of a normal and two variant cDNAs derived from the CYP2B locus on chromosome 19 and differential expression of the IIB mRNAs in human liver. , 1989, Biochemistry.

[30]  T. Aoyama,et al.  Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine. , 1989, The Journal of biological chemistry.

[31]  T. Shimada,et al.  Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA 1535/pSK1002. , 1989, Cancer research.

[32]  J. S. Miles,et al.  Close linkage of the human cytochrome P450IIA and P450IIB gene subfamilies: implications for the assignment of substrate specificity. , 1989, Nucleic acids research.

[33]  P. Watkins,et al.  Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients. , 1989, The Journal of clinical investigation.

[34]  I. Stupans,et al.  Identification and quantitation in human liver of cytochromes P-450 analogous to rabbit cytochromes P-450 forms 4 and 6. , 1988, Xenobiotica; the fate of foreign compounds in biological systems.

[35]  D. Nelson,et al.  Evolution of cytochrome P-450 proteins. , 1987, Molecular biology and evolution.

[36]  P. Watkins,et al.  Identification of a human liver cytochrome P-450 homologous to the major isosafrole-inducible cytochrome P-450 in the rat. , 1986, Molecular pharmacology.

[37]  J. Casazza,et al.  Identification of ethanol-inducible P-450 isozyme 3a as the acetone and acetol monooxygenase of rabbit microsomes. , 1985, The Journal of biological chemistry.

[38]  K. Kawajiri,et al.  Genetic Polymorphisms in the 5 '-Flanking Region Change Transcriptional Regulation of the Human Cytochrome P 45011 E 1 Gene ' , 2008 .

[39]  T. Aoyama,et al.  Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions. , 1992, Chemical research in toxicology.

[40]  D. Nelson,et al.  P450 gene nomenclature based on evolution. , 1991, Methods in enzymology.

[41]  D. Nebert,et al.  Evolution of the P450 gene superfamily: animal-plant 'warfare', molecular drive and human genetic differences in drug oxidation. , 1990, Trends in genetics : TIG.

[42]  D W Nebert,et al.  The Ah locus: genetic differences in toxicity, cancer, mutation, and birth defects. , 1989, Critical reviews in toxicology.

[43]  F. Gonzalez,et al.  Human cDNA‐Expressed Cytochrome P450 IA2: Mutagen Activation and Substrate Specificity , 1989, Molecular carcinogenesis.

[44]  Yves Morel,et al.  The molecular genetics of 21-hydroxylase deficiency. , 1989, Annual review of genetics.